Bank of America’s Cytokinetics CYTK Stock Holding History

Bank of America’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-41,000	Closed	-$2.25M	–	7562
2025 Q3	$2.25M	Buy	41,000 +32,000	+356%	+$1.32M	﹤0.01%	4731
2025 Q2	$297K	Hold	9,000	–	–	﹤0.01%	5995
2025 Q1	$362K	Sell	9,000 -31,000	-78%	-$1.42M	﹤0.01%	5831
2024 Q4	$1.88M	Buy	+40,000	New	+$2.08M	﹤0.01%	4498
2024 Q1	–	Sell	-411,600	Closed	-$34.4M	–	7812
2023 Q4	$34.4M	Buy	+411,600	New	+$14.9M	﹤0.01%	1649
2022 Q3	–	Sell	-30,000	Closed	-$1.18M	–	7898
2022 Q2	$1.18M	Buy	+30,000	New	+$1.21M	﹤0.01%	4771

Other funds holding CYTK

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Bank of America's CYTK Position: Q1 2026 in Review

Bank of America increased its Cytokinetics (CYTK) stake by 6.3% in Q1 2026, buying an estimated $11.7M and bringing the position to 3,125,436 shares worth $206M. The position accounts for 0.02% of the portfolio, ranked #723.

Bank of America first reported a position in CYTK in Q3 2013 and has held it in 51 quarters since. The position peaked at $335M in Q1 2024. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

Bank of America held 3,125,436 shares of Cytokinetics worth $206M as of Q1 2026.
Bank of America bought 184,284 Cytokinetics shares in Q1 2026, an estimated $11.7M.
Cytokinetics made up 0.02% of Bank of America's portfolio in Q1 2026, its #723 holding.
Bank of America first reported a position in Cytokinetics in Q3 2013 and has held it in 51 quarters since.
Bank of America's Cytokinetics position peaked at $335M in Q1 2024.
439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.